Timothy Springer invested $5 million in the startup’s early days. His windfall is one in a series of savvy investments.
Institute for Protein Innovation (IPI) unveils its new 12,000-square-foot laboratory and office facility at a ribbon cutting ceremony today
The minisymposium focused on solutions to reproducibility issues in the biological sciences and featured speakers from academia, industry, nonprofits, and publishing—including IPI President Steven Almo, Ph.D. and IPI board member Jeffrey Flier, M.D.
First Research Institution to Purchase Carterra’s High-Throughput Label-Free Biosensor to Support its Novel Antibody Discovery
IPI announced today the appointments of Steven Almo, Ph.D., as President; James Love, Ph.D., as Chief Operating Officer (COO); and Christopher D. Bahl, Ph.D., as Head of Protein Design. The new leadership team members join Joseph Jardine, Ph.D., Head of Antibody Discovery, who has been with IPI since its inception.
Scientist Timothy Springer has founded or financed some of biotechnology’s highest-profile companies. But for his latest entrepreneurial endeavor he’s taking an unusual tack: forming a nonprofit.
In an interview with Drug Discovery & Development, Springer explains what inspired the creation of the Institute for Protein Innovation and his vision for it going forward.
A behind-the-scenes look at the beginnings of Institute for Protein Innovation brought to you by Morphic Tx Studios.
Timothy Springer, Ph.D., a professor at Harvard Medical School and Boston Children’s Hospital, has always been interested in developing antibodies targeting proteins that are “extracellular”—meaning they reside in bodily fluids, outside of cell walls. But he found that the amount of funding provided to academicians who are studying such proteins was lacking. So he decided to create his own funding mechanism, the Institute for Protein Innovation (IPI), which launched in Boston today.
While genomics unveiled a wealth of information, including the identity of genes that lead to disease when mutated, researchers still do not fully understand what all the genes really do and how mutations change their function and cause disease.Now proteins are promising to provide the missing link.
Poster presented at The Protein Engineering Summit - PEGS2017 - Boston, MA May 1–5, 2017.